Wednesday, September 20, 2017
 
 
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Young America Capital Successfully Assisted Pleuratech in Entering Into an Exclusive Worldwide License Agreement With Merit Medical
 
(September 13, 2017)

NEW YORK, Sept. 13, 2017 /PRNewswire/ -- Young America Capital (YAC) is pleased to announce that it has successfully assisted Pleuratech in entering an exclusive worldwide license agreement with Merit Medical for Pleuratech's main product, a novel surgical device ensuring safe and accurate placement of drains in the pleural cavity.

Headquartered in Århus, Denmark, Pleuratech and its two founders, Niels Katballe and Peter Heydorn have developed the KatGuide, an innovate surgical device. The uniquely shaped, patented and clinically tested KatGuide can guide the chest tube to the part of the pleural cavity that needs drainage. With more successful surgeries and fewer misplaced drains as a result.

Merit Medical Systems (NASDAQ: MMSI) is a leading worldwide manufacturer of medical devices used primarily in cardiology, radiology and endoscopy. Merit employs approximately 4,500 people worldwide. In 2016, the company had a turnover of over $600 Million.   


The multimillion dollar license agreement means that the patented product is a giant step closer to becoming the industry standard for pleural drainage procedures.

"As a leading manufacturer and marketer of proprietary disposable medical devices, Merit Medical Systems, Inc. is excited to add the KatGuide to our current portfolio of products.  This innovative medical device delivers to clinicians a unique tool proven to improve the efficacy of chest tube placement. The resulting benefits will help ensure conditions for optimal drainage and, therefore, improve patient care," says Fred P. Lampropoulos, Merit's Chairman and CEO.

Young America Capital works with international early stage companies who seek investors or market access in the US. YAC's ability to assist Scandinavian companies is emphasized by having New York based Dane, Jakob Bergendorff, on our team to compliment a group of 35+ Investment Bankers focused on the lower middle market. Please contact us if you would like to learn more about our team and services.

About Young America Capital, LLC

Founded in 2000, Young America Capital is a New York-based FINRA/SEC/MSRB licensed independent investment banking and advisory firm which provides capital raising, M&A advisory and fund marketing services for companies and alternative investment fund managers. The company is comprised of a diverse group of senior investment banking professionals with particularly deep sector experience in Consumer & Retail, Energy & Clean-Tech, Technology, Media and Telecom, Healthcare & Life Sciences; Maritime, Infrastructure & Logistics, Financial Services & Fin-Tech, Real Estate, and Latin America.  www.yacapital.com

Media Contact:

Peter Formanek

914-777-0100

[email protected]

View original content:http://www.prnewswire.com/news-releases/young-america-capital-successfully-assisted-pleuratech-in-entering-into-an-exclusive-worldwide-license-agreement-with-merit-medical-300519294.html

SOURCE Young America Capital

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords: Inc., healthcare, medical technologists, Technology, Surgery, Business, Science, Financial, Marketing Services, Lifestyle, Medical Technology, Medical,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines